Editorial on article entitled: 'Effects of high intensity interval training on central hemodynamics and skeletal muscle oxygenation during exercise in patients with chronic heart failure' by Spee et al. 1 Exercise limitation is a well-established cardinal manifestation of the heart failure (HF) syndrome and its quantification through gas exchange analysis with objective measure of oxygen uptake (VO 2 ) provides the clinician with relevant information on pathophysiology and outcome. 2,3 Exercise training is an established and effective intervention that in HF improves exercise tolerance, enhances VO 2 at peak exercise and favourably affects the course of the disease. 4 For a long time, it has been axiomatic to interpret results of interventional trials, such as those observed with exercise training, only relying on significant changes in peak VO 2 without dissecting which organ system and pathway (central, peripheral or both) really mediate the improvement in exercise performance.
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This simple approach has obvious limitations because knowledge about specific mechanisms involved in the benefits of a therapeutic intervention provides the background for precision medicine and may yield to significant clinical advancements.
Most recent studies, especially performed in subjects with HF and preserved ejection fraction, have definitively changed this paradigm by looking at the variety of complex mechanisms that limit the oxygen (O 2 ) transport chain from air to mithocondria 5-7 and, through this, discerning how the physical therapeutic approach may work. 8 According to the Fick principle, VO 2 depends on cardiac output (CO) times O 2 artero-venous difference (A-VO 2 diff) and reflects the product of the integrated biological response of the heart and peripheral mechanisms involved in O 2 delivery (convection), diffusion and extraction during exercise. 9 Patients with HF are, by definition, limited in the O 2 convection (impaired CO and quite frequent reduction in O 2 content due to anaemia) 10 along with an impaired peripheral O 2 transport (diffusion) from blood to skeletal muscle. 11 Conversely, muscle ability to extract O 2 appears quite preserved. 11, 12 Due to these limitations, patients with HF show a slow VO 2 kinetics with a delayed increase of VO 2 after the onset of acute exercise and also prolonged recovery. 9 This delayed kinetics triggers a perturbation of intramuscular high energy phosphate, which exacerbates glycogenolysis, increases energetic costs and precipitates premature fatigue. The slow VO 2 kinetics decreases muscle efficiency and raises the O 2 deficit. 9 Exercise training is likely to be the best intervention to modulate the abnormalities in VO 2 kinetics favourably through a wealth of mechanisms that may vary depending on the type of programme, patient characteristics and HF stage. 13 Different exercise training types (endurance and resistance), modalities (continuous versus interval) and intensities (mild, moderate and high) protocols have been developed over time, but most of the evidence of a beneficial effect on HF comes from studies using moderate intensity continuous training (MCT). 14 Some recent lines of evidence have suggested the possibility that an 'overdose' of exercise through high intensity interval training (HIT; 85-95% of peak VO 2 with four intervals of 4 minutes, separated by 3 minutes active pauses for three times a week) may offer advantages compared to traditional MCT (30 minutes of 50-60% of peak VO 2 for three times a week).
Indeed a proof of concept single centre study indeed documented a HIT superiority in enhancing peak VO 2 by reversing left ventricular remodelling and improving CO and endothelial function response to a larger extent compared to MCT. 15 Fu et al. 16 confirmed these findings suggesting that the increase in VO 2 was secondary to the enhanced peak exercise stroke volume and CO with no significant changes in A-VO 2 diff.
These data, however, have been questioned and not been reproduced in a large multicentre trial, the SMARTEX-HF trial (forthcoming publication and preliminary data presented at the ESC Congress 2014), in which a large number of stable HF patients were randomly assigned in a 12-week programme to HIT, MCT programme or the control arm. No improvements in cardiac dimensions, nor differences in peak VO 2 between the two exercise training modalities were observed. Accordingly, some controversy has arisen, considering whether a HIT programme is a truly effective modality of intervention and what, if any, are the postulated additional mechanisms of benefits.
In the present issue of the journal, Spee and coworkers 1 attempt to answer some of these questions and shed new light on this issue.
They studied 26 HF patients randomly assigned 1:1 to a 12-week 4 Â 4 minute HIT programme at 85-95% of peak VO 2 or usual care. Usual care consisted in advising subjects to remain physically active according to standard recommendations but they were not monitored on their practices.
Patients performed a maximal and submaximal cardiopulmonary exercise testing with contemporary measurement of central and peripheral determinants of VO 2 .
The cardiac and peripheral contributions were indirectly quantified in the current study by pulse pressure contour analysis and near infrared spectroscopy, respectively.
The study results led to findings similar to the SMARTEX trial, confirming that HIT may work, because a significant increase in workload was observed, whereas absolute changes in peak VO 2 were not significant compared to standard care. Of note, some patients were classified as non-responders in terms of reverse cardiac geometry and exercise performance. The overall small number of patients, however, did not allow the pathophysiological background and the clinical phenotype typical of this subset of patients to be determined.
Given this limitation, the challenge is to understand how this specific intervention better matches with primary pathophysiological abnormalities encountered in exercise VO 2 kinetics. CO at rest increased by 7% but the observed improvement in submaximal VO 2 kinetics was not related to significant variations in CO during exercise, thus excluding a predominant HIT effect on the major determinant of O 2 delivery. No information was available on the haemoglobin content but presumably it did not change over time. On the contrary, the correlation found between VO 2 kinetic recovery and reduced muscle de-oxygenation points towards an HIT effect on the periphery. As O 2 extraction is the process less influenced by HF 9 and O 2 kinetic recovery is not influenced by O 2 utilization, 17 the disrupted local diffusive mechanisms in O 2 transport may be advanced as the mainstay target of HIT interventions.
It is very likely that therapeutic benefit on O 2 diffusion occurred by a training-induced improvement in capillary haemodynamics and nitric oxide bioavailability to increase the O 2 delivery-to-utilisation matching, but the present study does not help to determine what vascular and molecular mechanisms could be involved in this effect.
Nonetheless, observations have some value because, for the first time, they help to define what are the physiological correlates of HIT programmes in HF, and show that this approach may be suited to the pathophysiology of HF as it enhances muscle oxygenation without the need for major functional improvements in the failing heart. In addition, the present findings incite some relevant questions such as who is the beneficiary candidate and how many patients may really tolerate HIT, ensuring adherence over time. It is implicit that in this process of clarification the role of gender, age, body mass index, comorbidities, especially anaemia, and baseline haemodynamic characteristics have to be taken into account to sort out HIT prescription and interpreting clinical outcome.
These questions remain open but a step forward in the understanding of what can make an exercise training 'overdose' convenient at least for some HF patients has been provided by generating some different perspectives in planning future studies and carefully phenotyping the supposed responders.
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